SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook

Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others.

Analyst Commentary

Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance. This mix of moves feeds into the modest reduction in the overall average target and gives you a sense of where the market sees upside potential versus execution risk.

Bullish Takeaways

Bullish analysts have raised fair value estimates into the low to mid €20s, suggesting they see the current share price as not fully reflecting their assumptions on Solvay's earnings power.
Upward moves in price targets, such as revisions into the €22 to €25 range, point to confidence that Solvay can deliver on operational plans well enough to support these valuation levels.
Despite several downgrades, some research houses continue to cover the stock with targets that sit meaningfully above the lower end of the recent target range, indicating they still see scope for execution to close the gap toward their fair value views.

Bearish Takeaways

Bearish analysts have cut targets, including one large house trimming its view by €4. This feeds into the slight downtick in the consensus target and signals reduced conviction around upside.
Multiple downgrades to more cautious ratings and targets clustered around the low to high €20s reflect concerns about Solvay's ability to deliver against prior expectations without stretching valuation.
Ratings such as Sell and Underweight, even when paired with small price target lifts, show that some analysts see limited reward relative to perceived risks around earnings delivery and capital allocation.
Downgrades from more positive stances to Neutral suggest that, for a number of analysts, recent developments have shifted the balance toward a more wait and see view on execution and growth drivers.

What's in the News

Solvay has scheduled a Special or Extraordinary Shareholders Meeting for May 12, 2026, at 10:30 Romance Standard Time. This meeting could include votes on corporate actions that matter for you as a shareholder (company event notice).

Valuation Changes

Fair value was nudged down slightly from €25.47 to €25.34, implying only a small adjustment to the core valuation estimate.
The discount rate moved modestly lower from 8.18% to about 8.07%, which slightly increases the present value placed on future cash flows.
Revenue growth assumptions are effectively unchanged at around a 2.54% decline, so the model keeps a similar view on top line trends.
The profit margin remains broadly stable at roughly 6.94%, indicating no material shift in the earnings quality assumption per euro of sales.
The future P/E eased a bit from 10.99x to about 10.90x, pointing to a marginally lower valuation multiple being used in the updated model.

4 views

Key Takeaways

Expansion in rare earths and battery materials, alongside operational digitalization, positions Solvay for stronger asset utilization, margin gains, and long-term growth leadership.
Sustainability initiatives and supply chain localization strategies align with regulatory trends and premium pricing opportunities, further supporting future-proofing and profitability.
Prolonged pricing pressures, trade tensions, operational inefficiencies, and environmental liabilities threaten Solvay's revenue stability, margin strength, and future growth opportunities.

Catalysts

About Solvay

Provides basic and performance chemicals worldwide.What are the underlying business or industry changes driving this perspective?

Growing customer demand for rare earth production capacity outside of China-triggered by Chinese export controls and seeking greater supply chain localization-positions Solvay's La Rochelle plant for potential rapid expansion, paving the way for incremental high-value revenue streams and improved asset utilization in the coming years.
Advancement of digitalization initiatives (IoT, drones, process automation) is delivering consistent structural cost savings across Solvay's plants, which are expected to exceed interim targets and drive higher operating margins and earnings over the medium term.
Solvay's strategic focus on energy transition and sustainability (including reducing greenhouse gas emissions by 10% year-on-year and ongoing investments in green chemistry) is enabling the company to future-proof its portfolio, align with regulatory shifts, and benefit from premium pricing, positively impacting long-term margins and growth.
Ramp-up of new, highly competitive soda ash and rare earth capacities offers scope for improved profitability and share gains once market demand normalizes or supply rationalization (e.g., Chinese plant closures) occurs; this operational leverage may be underappreciated in the current valuation.
Increased customer interest and potential policy support for European battery materials and rare earths, driven by electrification and EV sector growth, creates an opportunity for Solvay to become a leading regional supplier, supporting sustained top-line growth and margin expansion over the long term.

Solvay Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Solvay's revenue will decrease by 2.5% annually over the next 3 years.
Analysts assume that profit margins will increase from 0.6% today to 6.9% in 3 years time.
Analysts expect earnings to reach €305.1 million (and earnings per share of €2.44) by about April 2029, up from €30.0 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €460.5 million in earnings, and the most bearish expecting €248.4 million.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 11.0x on those 2029 earnings, down from 97.0x today. This future PE is lower than the current PE for the GB Chemicals industry at 43.2x.
Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
To value all of this in today's terms, we will use a discount rate of 8.07%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Prolonged pricing pressure and decreased demand in key segments, particularly soda ash and Coatis, driven by high Chinese inventories, aggressive Asian competition, and global overcapacity, threaten to depress group revenues and net margins into 2026 and potentially beyond.
Heightened global trade tensions-especially tariffs between the U.S., Brazil, China, and the EU-are fueling demand uncertainty, destabilizing order volumes, and could structurally alter export flows, risking further revenue volatility and a long-term earnings drag.
Operational inefficiencies due to persistent industry underutilization (e.g., running plants below optimal utilization rates) are inflating cost per unit and weakening Solvay's EBITDA margins, with no clear indication of short-term market recovery to support a margin rebound.
Legacy and ongoing environmental liabilities, including high annual cash outflows for environmental remediation and litigation, are pressuring free cash flow and may require higher-than-expected provisions, potentially constraining capital for future strategic growth.
Delayed or uncertain expansion in strategic growth areas (e.g., rare earths) due to strict cash management, dependence on customer commitments, and unfavorable market conditions could limit Solvay's ability to capture long-term revenue opportunities, affecting its future earnings growth trajectory.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of €25.34 for Solvay based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €32.0, and the most bearish reporting a price target of just €20.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €4.4 billion, earnings will come to €305.1 million, and it would be trading on a PE ratio of 11.0x, assuming you use a discount rate of 8.1%.
Given the current share price of €27.84, the analyst price target of €25.34 is 9.8% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Solvay?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals